{"cluster": 46, "subcluster": 4, "abstract_summ": "In addition, various cardiovascular manifestations have been linked to the viral insult, including among others acute coronary syndromes, myocarditis, acute heart failure, cardiac injury, arrhythmias and acute pulmonary embolism.As the COVID-19 pandemic continues, more data regarding potential cardiovascular and cerebrovascular manifestations of the disease is required.In this context, special attention should be given towards COVID-19 patients with concurrent cardiovascular diseases, and special cardiovascular attention is warranted for treatment of COVID-19.The novel coronavirus disease (COVID-19) pandemic has already caused more than 300,000 deaths worldwide.Here we describe emerging evidence of the epidemiology of SARS-CoV-2 infection and underlying cardiovascular disease, the evidence for direct myocardial injury in SARS-CoV-2 infection, the specific presentations of cardiovascular involvement by SARS-CoV-2, and the cardiac effects of emerging treatments.For the infected patients, underlying cardiovascular comorbidities and especially existing cardiovascular disease seem to predispose to the development of cardiovascular complications, which are in turn associated with higher mortality rates.", "title_summ": "COVID-19 pandemic and cardiovascular disease: where do we stand?A Double-Edged Sword\u2014Cardiovascular Concerns of Potential Anti-COVID-19 DrugsCoronavirus Disease 2019 and Cardiovascular System: A Narrative ReviewCOVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular ResearchesAcute Coronary Syndromes and Covid-19: Exploring the Uncertainties.Cardiovascular implications of the COVID-19 pandemic: a global perspectiveCardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response2019 Novel-coronavirus: Cardiovascular Insights about Risk Factors, Myocardial Injury, Therapy and Clinical ImplicationsSARS-CoV-2 and Cardiovascular Complications: from Molecular Mechanisms to Pharmaceutical ManagementInvolvement of Cardiovascular System As The Critical Point in Coronavirus Disease 2019 (COVID-19) Prognosis and RecoveryCardiovascular Implications and Therapeutic Considerations in COVID-19 InfectionCOVID-19 Pandemic: Cardiovascular Complications and Future ImplicationsCOVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?Potential Effects of Coronaviruses on the Cardiovascular System: A Review.", "title_abstract_phrases": "More studies are needed to address the mechanism of cardiotoxicity and the treatments that can minimize permanent damage to the cardiovascular system.2019 Novel-coronavirus: Cardiovascular Insights about Risk Factors, Myocardial Injury, Therapy and Clinical ImplicationsFrom December 31th, 2019, a novel highly pathogenic coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide, reaching at present the dimension of a pandemic.For the infected patients, underlying cardiovascular comorbidities and especially existing cardiovascular disease seem to predispose to the development of cardiovascular complications, which are in turn associated with higher mortality rates.In this context, special attention should be given towards COVID-19 patients with concurrent cardiovascular diseases, and special cardiovascular attention is warranted for treatment of COVID-19.Involvement of Cardiovascular System As The Critical Point in Coronavirus Disease 2019 (COVID-19) Prognosis and RecoveryThe novel coronavirus disease (COVID-19) pandemic has already caused more than 300,000 deaths worldwide.COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular ResearchesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells following binding with the cell surface ACE2 receptors, thereby leading to coronavirus disease 2019 (COVID-19).Here we describe emerging evidence of the epidemiology of SARS-CoV-2 infection and underlying cardiovascular disease, the evidence for direct myocardial injury in SARS-CoV-2 infection, the specific presentations of cardiovascular involvement by SARS-CoV-2, and the cardiac effects of emerging treatments."}